AstroNova (ALOT) Cash & Equivalents (2010 - 2026)

AstroNova has reported Cash & Equivalents for 17 years, with the latest figure at $4.7 million in Q2 2026.

• Quarterly Cash & Equivalents fell 12.67% year-over-year to $4.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $4.7 million (down 12.67% YoY) and the FY2026 annual result came in at $4.1 million, down 19.37% from the prior year.
• Cash & Equivalents climbed to $4.7 million in Q2 2026 per ALOT's latest filing, from $4.1 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $5.8 million in Q2 2022 and troughed at $3.6 million in Q4 2025.
• A 5-year average of $4.6 million and a median of $4.5 million in 2023 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents tumbled 62.38% in 2022, then surged 34.16% in 2025.
• Over 5 years, Cash & Equivalents stood at $4.5 million in 2022, then rose by 7.36% to $4.8 million in 2023, then fell by 8.18% to $4.4 million in 2024, then dropped by 18.64% to $3.6 million in 2025, then advanced by 29.65% to $4.7 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $4.7 million, $4.1 million, and $3.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.